Children and young people are increasingly likely to receive information regarding inherited health risks relevant to their genetic relatives and themselves. We reviewed the literature to determine what children and young people (21 years and younger) understand about inherited conditions and their attitudes towards genetic testing. We screened 1815 abstracts to identify 20 studies representing the perspectives of 1811 children and young people between the ages of 6 and 21 years (1498 children or young people at general population-level risk from 9 studies, 313 affected/at risk from 15 studies). Children and young people at general population-level risk demonstrated a basic understanding that disease predisposition can be inherited within families. Those affected by or at risk of genetic conditions inferred their genetic status from observable, relational characteristics within their family and the results of personal genetic testing if it had occurred, but some misunderstandings of important genetic concepts were evident. Children and young people expressed interest in and a willingness to undertake personal genetic testing, but also articulated concerns about the limitations and risks of testing. Paediatric patients require developmentally-sensitive genetic counselling and support in navigating the unique landscape of their condition.
The extent to which children and young people can understand and use genetic information about their health risks is dependent on their cognitive and emotional maturity. Studies investigating health knowledge within this group indicate that even children as young as 5 years old can actively theorise about biological aspects of the world, 4, 5 including disease processes such as contagion. 6, 7 Although there is evidence that pre-school children have an understanding of kinship relationships and the concept that physical characteristics can be inherited within families, 8, 9 the developmental trajectory that leads to a more advanced theory of biological inheritance is less well defined. 10, 11 The results obtained from genetic-and increasingly genomictesting are complex and may have lifelong consequences. Genetic health information requires an ability to think about one's health at both an individual and family-level. 12 As children enter adolescence additional psychosocial considerations arise, such as the meaning of the genetic test result for the identity of the young person and potential impact on peer and intimate relationships. 13 As children and young people enter adulthood they may be required to think generationally; for example, considering the impact on the health of future offspring in the context of family planning as well as on that of their parent/s and other genetic relatives. The ability to interpret concepts of risk, susceptibility and predisposition requires an understanding of probability that even adults may struggle to grasp. 14 Genetic test results may also require an ability to understand and tolerate uncertainty. 15, 16 Taken together, the complexity of genetic testing opens up the potential for misinterpretation and misunderstandings in children and young people.
In the context of children and young peoples' understanding and knowledge it is important to consider the role of family communication. Recent reviews indicate that although parents hold largely positive attitudes towards childhood genetic testing, 17 miscommunication and misinformation are common in families affected by genetic conditions. 18 Parents may find it difficult to communicate openly with their children about the potential impact of a genetic condition, due in part to feelings of guilt. 1 In children and young peoples' broader social context, information about disease, genetics and risk is increasingly present in the media and can influence personal knowledge and misinformation. 19 Several authors have suggested an important role for the school curriculum in ensuring that children receive accurate and developmentally appropriate information about genetics and the associated ethical and legal issues. [20] [21] [22] Knowledge and understanding of genetics may also differ across cultures. 23 Strong scientific literacy and, more specifically, genetic literacy is essential for young people born in the "genomic era."
Children's involvement in decision-making about their health is a perennially contentious issue. 24 Although the legal perspective that children below a jurisdiction-specified age are unable to provide informed consent is rarely challenged, it would be wrong to assume that children, especially adolescents, do not have the cognitive capacity to actively engage in discussions about their health. 25 In some cases, a child below the age of 16 may be able to make decisions about their healthcare without parental involvement, if they are determined through legal processes to have sufficient maturity and intellectual capacity (referred to as "Gillick competence"). 25 In the context of childhood pre-symptomatic and predictive testing, clinical guidelines commonly recommend that children and young people should participate at some level in discussions about the implications of genetic testing. 3, 26, 27 However, if the nature of these discussions is to be judged on a case-by-case basis "…in a manner that is appropriate for their age and understanding", 27 developmentally informed guidance is required. A deeper appreciation of children and young peoples' understanding of genetic concepts and genetic testing will act to scaffold parents' and healthcare providers' communication with children about their genetic health risks.
We conducted this review as impetus for further "bottom-up"
child-focused health research in which children and young people are given the space to articulate what they understand and think about issues related to hereditary illness predisposition that may impact them. 28, 29 As an extension of previous reviews in this area 30 and in the context of the "unstoppable train" 31 of genetic technologies, we aimed to provide an up-to-date summary of children and young peoples' perspectives on clinical genetic testing.
| Objectives
This review asked the following questions: 33 We exported the search results to EndNote X7
(Thomas Reuters). Our final search was conducted in September 2017.
| Inclusion/exclusion criteria
Articles were included if they: 3. Were systematic reviews, narrative reviews, case studies, commentaries, editorials or opinion pieces.
| Quality analysis
We used the QualSyst tool 35 to determine the risk of bias of included studies. One author (B.M.) carried out the analysis and a second author (J.V.) independently rated 20% of the included studies, with any discrepancies resolved through discussion. Studies were rated according to either qualitative or quantitative criteria, with mixedmethod designs subjected to both scoring systems. To ensure fairness in ratings, if the studies included both qualitative and quantitative elements but were not explicitly stated to be mixed methods then only the primary research design was evaluated. As per the QualSyst scoring system, the total possible score for quantitative studies varies according to the number of items "not applicable" to the study (eg, random allocation of participants in observational analytic studies).
Quality scores were defined as limited (<50%), adequate (50%-70%), good (71%-80%) or strong (>80%; see Table 1 ).
18,36
| Data extraction
We identified 1815 articles after screening for English-only, human studies and de-duplicating ( Figure 1 ). Two authors (B.M. and J.V.) independently screened the titles and abstracts (with an inter-rater agreement of 89%), and any disagreements were resolved through discussion.
Full-texts were reviewed for any abstracts that did not yield sufficient information to determine eligibility. Of the 41 reviewed full-texts, 11 studies met our inclusion criteria. An additional nine eligible studies were found through study reference lists and Google scholar.
One author (B.M.) extracted data from all 20 studies and another author (J.V.) independently extracted data for 20% of studies (randomly selected) to monitor accuracy of the process. In addition to information regarding study design and sample(s), where possible we also extracted information about predictors of children and young peoples' understanding and attitudes, and differences in understanding and/or attitudes between groups (eg, general population-level risk vs from families with a history of breast cancer).
Similar to a recent psychosocial review examining parents' attitudes towards genetic testing, 17 we divided results according to current clinical guidelines concerning genetic testing in children and young people. 3, 26, 27 We distinguished between studies which focused on conditions for which genetic testing (either predictive testing or diagnostic testing) is clinically indicated in childhood, and conditions for which genetic testing is only recommended in adulthood or "emerging adulthood."
3 | RESULTS
| Study characteristics
Twenty studies representing the views of 1811 children and young people aged between 6 and 21 years were identified (1498 children or young people at general population-level risk from 9 studies, 313 affected/at risk from 15 studies). A minority of studies [37] [38] [39] [40] [41] (n = 5) investigated the perspectives of children 10 years or younger.
Eleven studies 38, [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] described their attitudes towards clinical genetic testing.
| Methodological rigour
Eleven studies were qualitative and nine were quantitative using a cross-sectional, descriptive design. QualSyst scores ranged from 75% to 100%, with the majority of articles scored as strong (>80%), indicating a low risk of bias. As all studies were of at least "good" quality, the results did not need to be qualified by a discussion of the studies' methodological rigour.
3.3 | Children and young peoples' understanding of clinical genetics (n = 13 studies)
| Conditions for which genetic testing in childhood is clinically indicated
Studies indicated that adolescents and young people affected by or at risk for autosomal dominant and recessive conditions generally understand that disease predisposition can be inherited within families and, where testing had occurred, hold mostly accurate knowledge of their personal genetic status (n = 5). 39, 42, 47, 52, 54 Only one study investigated young peoples' understanding of X-linked conditions. 54 When asked directly about their knowledge of the heritability of familial adenomatous polyposis (FAP), adolescents who had parents diagnosed with FAP indicated they knew that FAP was heritable and associated with cancer risk. 39 Similarly, adolescents with cystic fibrosis (CF) demonstrated good "general knowledge" (measured by the percentage of objectively correct answers) of patterns of inheritance within families. 52 Young people who had genetic testing for acute (Continues) (Continues) (Continues) (Continues) The total possible quality score for the quantitative studies varied according to which scoring items were relevant to the study.
b
Other participant groups other than children and young people also noted.
c Age refers to age at study participation unless otherwise stated. Participant gender specified where possible.
d Some presented to participants in a hypothetical scenario.
intermittent porphyria (AIP) as minors demonstrated knowledge of their genetic status, 42 as did adolescents with phenylketonuria (PKU) or congenital adrenal hyperplasia (CAH). 47 Studies also showed that adolescents tend to know their future reproductive risks, demonstrated in the case of PKU/CAH 47 and in sisters of males with X-linked chronic granulomatous disease (CGD). 54 Some gaps in understanding were also identified. Generally, studies (n = 4) 39,41,46,52 indicated that children and young peoples' understanding of heritability was grounded in observable family experience rather than knowledge of specific genes or carrier rates. For example, youth with sickle cell disease (SCD) demonstrated limited understanding of the inheritance of SCD and did not know the probability of passing SCD to their offspring. 46 In addition, adolescents with CF did not know the incidence and carrier rates of CF. 52 Misconceptions may be related to misunderstanding of more complex medical concepts (eg, chromosomes), as was demonstrated in the case of siblings of children with rare disorders. 41 Further, although AIP-mutation carriers generally knew their genetic status, some demonstrated confusion about the symptoms of clinically manifest AIP. 42 
| Conditions for which genetic testing in emerging adulthood/adulthood is clinically indicated
Three studies investigated children and young peoples' understanding of breast cancer genetics (BRCA1/2; autosomal dominant). 40, 43, 51 Two studies reported that children as young as 11 years of age from families with a strong history of breast cancer understood they were at increased risk of breast cancer due to familial/genetic risk. 43, 51 The majority of adolescent girls at general population-level risk for breast cancer did not indicate they were at elevated risk of breast cancer. 43 Adolescent girls at general population-risk for breast cancer did not demonstrate specific knowledge of BRCA1/2 genes, 43 nor did females with a strong family history. 43, 51 From a small qualitative study there is some evidence that young people in families with a history of breast cancer may have limited understanding of their own health risks due to inhibited risk disclosure by parents, especially to male children in the family. 40 A basic understanding of hereditary conditions and genetic concepts (eg, DNA) was also evident in a community sample of schoolaged adolescents, 53 as well as children 7 to 10 years old. 38 One study indicated that although a community sample of adolescents had "heard of" genetic testing and were familiar with some genetic concepts related to the Human Genome Project, younger adolescents (14-17 years old) demonstrated very little in-depth knowledge of either genetics or genetic testing for disease susceptibility. 
| Factors that may influence children and young peoples' understanding of clinical genetics
Five studies provided insight into the factors that may influence children and young peoples' understanding. 40, 43, 51, 53, 55 Studies suggest that "younger" adolescents (11 to 13-year olds in one study, 43 and 14 to 17-year olds in another 55 ) may know less about concepts related to genetics and genetic testing than "older" adolescents (older than 13 years, 43 and 18 to 21-year olds 55 ). Two studies suggest that Five studies indicated that children and young people were generally receptive to the idea of childhood genetic testing for disease predisposition. 37, 42, 53, 54, 56 The majority of secondary school students in one study indicated positive attitudes and a willingness to take up genetic testing for hereditary haemochromatosis (autosomal recessive). 53 Those who had genetic testing for AIP (autosomal dominant)
indicated that knowledge of their risk status was useful, 42 , and others at-risk or affected by other autosomal dominant 56 or recessive conditions 54 also indicated benefits to accessing testing. Nevertheless, participants' attitudes were commonly tempered by an appreciation of some of the possible risks associated with testing (n = 4/5 studies; see 40 In many cases, positive attitudes were tempered by concerns, namely the potential for a negative psychological impact as a result of knowing one's genetic risk (n = 5/8 studies; see Table 2 ).
Young people who had undergone predictive testing for other adult-onset autosomal-dominant conditions held a variety of attitudes towards testing across both positive and negative test results. 50, 56 A small number of young people in one study felt disempowered when testing was discouraged or delayed, but this did not include the perspectives of young people with a Huntington's disease (HD) genepositive test result. 50 Young people from HD families in another study demonstrated mixed perspectives about the appropriate timing of HD predictive testing, and described various concerns and benefits. 49 When presented with a hypothetical scenario involving genetic testing for disease susceptibility, children and young people at risk of coronary artery disease initially held favourable attitudes towards testing, although this was tempered by concerns about negative psychological impact. 37 A community sample of adolescents also held positive attitudes towards genetic testing in the context of future reproductive planning. 44 Overall, concerns about the potential risks or limitations of testing were noted by participants in the majority of studies (n = 6/8; Table 2 ).
| Factors that may influence children and young peoples' attitudes towards clinical genetic testing
Three studies provided insight into the factors that may influence children and young peoples' attitudes. 45, 51, 53 Children and young people with a family history 45, 51 or who are in ethnic groups at high risk for hereditary disease predisposition 45 appear more willing to undergo genetic testing than those from lower-risk groups. Those 
Concerns Benefits
Conditions for which genetic testing in childhood is clinically indicated.
Negative psychological impact (eg, worry, low mood, regret). 37, 42, 54, 56 Informed future reproductive decision-making. 54 Knowledge of risk status. 37, 42 Stigma. 54 Early lifestyle modification for management of the condition. 37, 42 Poor understanding of implications if tested too young. 42 Privacy and misuse of results. 37 Disease prevention may not be possible. 37 Conditions for which genetic testing in emerging adulthood/ adulthood is clinically indicated.
Negative psychological impact (eg, nervousness, stress). 37, 45, [49] [50] [51] Prompt lifestyle changes (eg, increased screening, prophylactic procedures). 37, 40, 45, 48, 51 Regret knowledge of genetic status. 56 Desire for cosmetic breast augmentation (in the context of a BRCA gene mutation). 40 Privacy concerns and misuse of results. 45 Impact on relationships/stigma. 37, 56 Interference with other important aspects of life (eg, schooling).
56
Informed future reproductive decisionmaking. 40, 44, 48, 49 Positive psychological impact (eg, relief from uncertainty). [48] [49] [50] 56 Sense of control/mastery in managing the condition. 56 Strengthening of relationships through the testing experience. 56 with higher perceived knowledge regarding genetic conditions 53 and who perceive benefits to genetic testing in terms of condition management 45 may also be more willing to undergo testing. There is evidence that children and young people demonstrate a basic understanding of inheritance that is mainly grounded in observable, relational information such as family history. Although studies with younger children were sparse, one small qualitative study provided a preliminary indication that this level of understanding may be evident in 7 to 10 year-olds. 38 However, young adolescents in the general community may have very little knowledge of more complex genetic concepts or genetic testing. 55 Importantly, children and young people in families with a strong history of a condition (eg, breast cancer and/or BRCA1/2 mutations) typically understand they are at increased risk of the condition. 43, 51 We also found that young patients who had had genetic testing were generally able to accurately report their genetic status. 42, 47 However, these results are balanced with evidence that children and young people may not understand patterns of inheritance or misunderstand specific genetic concepts; for example, the name of the gene involved, carrier or penetrance rates, or what it means to be a carrier of a genetic mutation.
| DISCUSSION
Although we may not expect a high level of genetic knowledge in children and young people who are not at-risk, an understanding of these concepts may be more critical for children and young people affected by or at-risk of genetic conditions. Although from a small number of studies, the results also point to specific groups of young people who may require more in-depth counselling and/or information provision to ensure they accurately understand their personal risks; for example, adolescent and young adult males with a strong family history of breast cancer or where a predisposing mutation has been identified, 57 and young people with SCD. 46 Family-based communication interventions may be particularly crucial in families where parents' ability to effectively communicate with their children about genetic risks and potentially life-saving prophylactic procedures may be compromised by anxiety or guilt. 40 Children and young peoples' attitudes towards clinical genetic testing in both childhood and emerging adulthood/adulthood appeared open and interested. The finding that some young people from families affected by Huntington disease and other adult-onset conditions felt disempowered and frustrated when predictive genetic testing was delayed until adulthood 49, 56 speaks to the tension between clinical judgement and children and young peoples' desire for information, and the ongoing debate as to whether uncertainty or knowing one's genetic status presents the greatest emotional burden. 58 However, it is crucial to note that the Duncan et al 56 
| Limitations
Only a small proportion of the abstracts identified by our search terms were eligible for inclusion, primarily as a result of the age-range criteria. Although our decision to specify 21 years or younger was pragmatic and intended to maximise the relevance of this review to the paediatric setting, we acknowledge our narrow definition of "young people." In addition, our search was limited to papers published in English, potentially eliminating other relevant articles.
Although the reviewed studies were all of at least "good" quality, we 
